Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Durcan

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Neurology|June 6, 2018
Teaching NeuroImages: Dyke-Davidoff-Masson syndromeRobert Durcan, Shane Smyth, Ferdia Bolster
Brain Communications|September 4, 2025
Noradrenergic therapies in neurodegenerative disease: from symptomatic to disease modifying therapy?Robert Durcan, Claire O'Callaghan, James B Rowe
Practical Neurology|August 1, 2018
Guillain-Barré syndrome mimicking botulism in early disease courseRobert Durcan, Olwen Murphy, Valerie Reid, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|January 19, 2017
Hydroxychloroquine-Induced Erythema MultiformeNour Abou Assalie, Robert Durcan, Laura Durcan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersRobert Durcan, Amanda J Heslegrave, Peter Swann, et al.
Movement Disorders Clinical Practice|November 21, 2019
A Rare Presentation of Paraneoplastic Striatal Encephalitis Associated with Nonsmall Cell Lung CancerAnne M O'Mahony, Robert Durcan, Orla Touhy, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 27, 2025
Novel blood-based proteomic signatures across multiple neurodegenerative diseasesRobert Durcan, Amanda Heslegrave, Peter Swann, et al.
BMJ Open|July 29, 2025
Noradrenaline for progressive supranuclear palsy syndromes (NORAPS): a randomised, double-blind, placebo-controlled, crossover Phase IIb clinical trial evaluating the efficacy and safety of oral atomoxetine for treating cognitive and behavioural changes in people with progressive supranuclear palsy syndromes in the UKRobert Durcan, Hugo Paula, Boyd C P Ghosh, et al.
Brain Communications|December 19, 2025
Inflammation PET and plasma neurofilament light predict survival in people with progressive supranuclear palsyNoah L Shapiro, Peter Simon Jones, Elijah Mak, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Neurology|June 6, 2018
Teaching NeuroImages: Dyke-Davidoff-Masson syndromeRobert Durcan, Shane Smyth, Ferdia Bolster
Brain Communications|September 4, 2025
Noradrenergic therapies in neurodegenerative disease: from symptomatic to disease modifying therapy?Robert Durcan, Claire O'Callaghan, James B Rowe
Practical Neurology|August 1, 2018
Guillain-Barré syndrome mimicking botulism in early disease courseRobert Durcan, Olwen Murphy, Valerie Reid, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|January 19, 2017
Hydroxychloroquine-Induced Erythema MultiformeNour Abou Assalie, Robert Durcan, Laura Durcan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersRobert Durcan, Amanda J Heslegrave, Peter Swann, et al.
Movement Disorders Clinical Practice|November 21, 2019
A Rare Presentation of Paraneoplastic Striatal Encephalitis Associated with Nonsmall Cell Lung CancerAnne M O'Mahony, Robert Durcan, Orla Touhy, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 27, 2025
Novel blood-based proteomic signatures across multiple neurodegenerative diseasesRobert Durcan, Amanda Heslegrave, Peter Swann, et al.
BMJ Open|July 29, 2025
Noradrenaline for progressive supranuclear palsy syndromes (NORAPS): a randomised, double-blind, placebo-controlled, crossover Phase IIb clinical trial evaluating the efficacy and safety of oral atomoxetine for treating cognitive and behavioural changes in people with progressive supranuclear palsy syndromes in the UKRobert Durcan, Hugo Paula, Boyd C P Ghosh, et al.
Brain Communications|December 19, 2025
Inflammation PET and plasma neurofilament light predict survival in people with progressive supranuclear palsyNoah L Shapiro, Peter Simon Jones, Elijah Mak, et al.
Pageof 1